期刊文献+

老年黄斑变性患者与对照人群膳食、血清叶黄素/玉米黄素以及血脂水平的比较 被引量:13

Comparison of daily intake of lutein + zeaxanthin,serum concentration of lutein /zeaxanthin and lipids profile between age-related macular degeneration patients and controls
下载PDF
导出
摘要 目的:比较老年黄斑变性(age-related macular degeneration,AMD)患者与对照人群膳食和血清中叶黄素、玉米黄素及血脂水平。方法:根据眼底形态学及年龄相关性眼病研究(age-related eye disease study,AREDS)的标准对AMD进行诊断与分级,募集早期AMD患者、中期AMD患者及非AMD对照各51人。采用食物频率调查法,分析膳食叶黄素+玉米黄素的每日摄入量;采用高效液相色谱法测定血清叶黄素及玉米黄素水平;采用罗氏全自动生化分析仪测定血脂(总胆固醇、甘油三酯、高密度脂蛋白、低密度脂蛋白)水平。结果:中期AMD组膳食叶黄素+玉米黄素摄入量、血清叶黄素及玉米黄素水平分别为7 870.458μg/d、0.180μmol/L、0.029μmol/L,均低于对照组(11 297.959μg/d、0.285μmol/L、0.044μmol/L,P<0.05);早、中期AMD组血清高密度脂蛋白水平分别为(1.29±0.27)mmol/L、(1.16±0.30)mmol/L,均低于对照组[(1.45±0.35)mmol/L,P<0.001]。结论:膳食叶黄素+玉米黄素的摄入量和血清叶黄素、玉米黄素水平可能影响AMD的发展进程,血清高密度脂蛋白水平可能与AMD的发生相关。 Objective:To compare the daily intake of lutein ± zeaxanthin, serum concentrations of lutein, zeaxanthin and serum lipids between age-related macular degeneration (AMD) patients and controls. Methods: AMD was diagnosed and graded according to the fundus morphology and the standard of agerelated eye disease study (AREDS). In the study, 51 subjects with early AMD, 51 with medium AMD and 51 without AMD as controls were recruited. Food frequency questionnaires were used to calculate the daily intake of lutein and zeaxanthin. The concentrations of serum lutein and zeaxanthin were measured by HPLC and the concentrations of serum lipids including serum total cholesterol (TC), triglyceride (TG), high density lipoprotein (I-IDL) and low density lipoprotein (LDL) were measured by Roche full- automatic biochemical analyzer. Results: The daily intake of lutein ± zeaxanthin, the concentrations of serum lutein and serum zeaxanthin of the subjects with medium AMD were 7 870. 458 μg/d, 0. 180 p.mol/L, 0. 029 μmol/L respectively, which were all significantly lower than those of the controls ( 11 297. 959 μg/d, 0. 285 μmol/L, 0. 044 μmol/L, P 〈 0.05 ) ; The concentrations of serum HDL of the subjects with early and medium AMD were ( 1.29 ± 0.27 ) mmol/L and ( 1.16 ± 0.30) mmol/L respectively, both of which were significantly lower than that of the controls [ ( 1.45 ± 0.35 ) mmol/L, P 〈 0. 001 ]. Conclusion: The development of AMD might be affected by the daily intake of lutein + zeaxanthin and the serum concentrations of lutein and zeaxanthin. The concentration of serum HDL might be related to the occurrence of AMD.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2014年第2期237-241,共5页 Journal of Peking University:Health Sciences
基金 国家自然科学基金(30872113)资助~~
关键词 黄斑变性 叶黄素 膳食 血清 玉米黄素 Macular degeneration Lutein Diet Serum Zeaxanthin
  • 相关文献

参考文献32

  • 1Resnikoff S, Pascolini D, Etya' Ale D, et al. Global data on visu- al impairment in the year 2002 [ J ]. Bull World Health Organ, 2004, 82(11): 844-851.
  • 2Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related maeular degeneration : the Blue Mountains Eye Study [ J ]. Ophthalmology, 2008, 115 ( 2 ) : 334 - 341.
  • 3Gale CR, Hall NF, Phillips DI, et al. Lutein and zeaxanthin sta- tus and risk of age-related macular degeneration [ J]. Invest Oph- thalmol Vis Sei, 2003, 44(6) : 2461 -2465.
  • 4Moeller SM, Parekh N, Tinker L, et al. Associations between in- termediate age-related maeular degeneration and lutein and zeaxan- thin in the Carotenoids in Age-related Eye Disease Study ( CAREDS ) : ancillary study of the Women' s Health Initiative [J]. Arch Ophthalmol, 2006, 124(8) : 1151 -1162.
  • 5Cardinauh N, Abalain J H, Sairafi B, et al. Lycopene but not lu- tein nor zeaxanthin decreases in serum and lipoproteins in age-re- lated macular degeneration patients [ J]. Clin Chim Acta, 2005, 357 ( 1 ) : 34 - 42.
  • 6Daseh B, Puhs A, Sehmidt J, et al. Serum levels of maeular ea- rotenoids in relation to age-related maculopathy: the Muenster Ag- ing and Retina Study (MARS) [ J]. Graefes Arch Clin Exp Ophthalmol, 2005, 243(10) : 1028 - 1035.
  • 7Cho E, Hankinson SE, Rosner B, et al. Prospective study of lute- infzeaxanthin intake and risk of age-related macular degeneration [J]. Am J Clin Nutr, 2008, 87(6) : 1837 -1843. - 769.
  • 8Connor WE, Duell PB, Kean R, et al. The prime role of HDL to transport lutein into the retina: evidence from HDL-defieient WHAM ehicks having a mutant ABCA1 transporter [ J ]. Invest Ophthalmol Vis Sei, 2007, 48 (9) : 4226 - 4231.
  • 9Wang W, Connor SL, Johnson E J, et al. Effect of dietary lutein and zeaxanthin on plasma earotenoids and their transport in lipo- proteins in age-related maeular degeneration [ J ]. Am J Clin Nutr, 2007, 85 (3) : 762.
  • 10Abalain JH, Carre JL, Leglise D, et al. Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels? [ J]. Clin Chim Acta, 2002, 326(1 -2) : 97 - 104.

二级参考文献68

  • 1邹海东,张晳,许迅,汪枫桦,张世杰.上海市静安区曹家渡街道年龄相关性黄斑变性的患病率调查[J].中华眼科杂志,2005,4(1):15-19. 被引量:107
  • 2惠伯棣,李京,裴凌鹏.应用C_(30)-HPLC-PDA分离与鉴定食品中全反式叶黄素和玉米黄素[J].食品科学,2006,27(9):151-154. 被引量:13
  • 3宋新娜,汪之顼.美国的食物类胡萝卜素含量数据[J].国外医学(卫生学分册),2007,34(3):182-187. 被引量:14
  • 4杨月欣,王光亚,潘兴昌,主编.中国食物成分表2004[M].北京:北京大学出版社,2004.15-18.
  • 5Krinsky NI,Landrum JT,Bone RA.Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye.Annu.Rev.Nutr.2003.23:171-201.
  • 6Tan JS,Wang JJ,Flood V,et al.Dietary antioxidants and the long-term incidence of age-related macular degeneration:the Blue Mountain Eye Study.Ophthalmol.2008,115:334-341.
  • 7Vu HT,Robman L,Hodge A,et al.Lutein and zeaxanthin and the risk of cataract:the Melbourne visual impairment project.Invest Ophthalmol Vis Sci.2006,47:3783-3786.
  • 8Dwyer JH,Navab M,Dwyer KM,et al.Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis:the Los Angeles atherosclerosis study.Circulation.2001,103(24):2922-2927.
  • 9Richer S,Stiles W,Statkute L,et al.Double-masked,placebo-controlled,randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration:the Veterans LAST study (Lutein Antioxidant Supplementation Trial).Optometry.2004,75:216-230.
  • 10Palombo P,Fabrizi G,Ruocco V,et al.Beneficial longterm effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin:a double-blind,placebo-controlled study.Skin Pharmacol Physiol.2007,20:199-210.

共引文献1065

同被引文献144

引证文献13

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部